FDA’s finding that reports on adverse events for Plan B formulas do not raise pediatric safety concerns supports full over-the-counter access to emergency contraceptive products containing the ingredient levonorgestrel, reproductive rights advocates say.
In a recent review of adverse event reports submitted from 2002 through 2010, FDA found only 13 reports...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?